Detalles de la búsqueda
1.
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 205(2): 227-239, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273214
2.
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 20(9): 1226-1238, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402321
3.
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Breast Cancer Res Treat
; 176(2): 377-386, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31041683
4.
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704775
5.
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer
; 180: 108-116, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592505
6.
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
; 41(33): 5118-5130, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556775
7.
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
J Clin Oncol
; 40(5): 449-458, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995105
8.
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8.
Clin Cancer Res
; 27(21): 5931-5938, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380638
9.
Commentary on "Prognosis according to the timing of recurrence in breast cancer" (Ann Surg Treat Res 2023;104:1-9).
Ann Surg Treat Res
; 106(4): 237-238, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586550
10.
Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Clin Cancer Res
; 25(13): 3865-3872, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064782
Resultados
1 -
10
de 10
1
Próxima >
>>